Do GLP-1 Medications Increase Cancer Risk?
Last updated: January 2026
Quick Answer
Rodent studies showed thyroid tumors at high doses, but human data has not confirmed this risk. GLP-1 medications are contraindicated only for those with medullary thyroid carcinoma history.
Do GLP-1 Medications Increase Cancer Risk
Rodent studies showed thyroid tumors at high doses, but human data has not confirmed this risk. GLP-1 medications are contraindicated only for those with medullary thyroid carcinoma history.
Safety is the most important consideration when starting any medication. GLP-1 medications have been extensively studied in clinical trials involving tens of thousands of patients, and they have a well-established safety profile when prescribed and monitored by licensed healthcare providers.
What the Research Shows
The STEP and SURMOUNT clinical trial programs included over 25,000 participants combined. These large-scale studies established the efficacy and safety profile that led to FDA approval for weight management.
Staying Safe on GLP-1 Treatment
- Only obtain GLP-1 medications through licensed healthcare providers and pharmacies
- Follow your prescribed dosing schedule and titration plan
- Report any unusual symptoms to your provider promptly
- Attend regular follow-up appointments for monitoring
- Inform all your healthcare providers that you take GLP-1 medications
- Keep medications stored properly and check expiration dates
Related Questions
Are GLP-1 Medications Safe for Long-Term Use?
GLP-1 medications have been studied for up to 5 years with acceptable safety profiles. Long-term data continues to accumulate as these medications become more widely used.
Can You Take GLP-1 Medications with Thyroid Issues?
GLP-1 medications are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome. Other thyroid conditions may be OK with monitoring.